|
Tambutin Tablet Ranked Top 3 in the Antispasmodic Category at the Russian Pharmaceutical Awards for Two Consecutive Years
2017.12.14
|
|---|
|
Tambutin Tablet (export name: Trimedat) wereed as one of the Top 3 Best Drugs in the Antispasmodic category for the second consecutive year at the Russian Pharma Awards ceremony held last month in Moscow, Russia.
The Top 3ion was determined through anonymous voting by over 500,000 medical professionals registered on “Doctor at Work,” the largest professional network in Russia. The award carries special significance as the evaluation is made objectively by local healthcare specialists who assess the convenience and efficacy of pharmaceutical products.
Tambutin Tablet (Trimebutine Maleate) are a convenient gastrointestinal motility regulator with various therapeutic benefits, restoring the normal physiological activity of muscles in different parts of the digestive tract. The product is on track to achieve annual sales of 5 billion KRW in Russia alone.
To further enhance brand awareness, Daehan New Pharm launched a large-scale advertising campaign in October across online platforms and ten regional TV stations in Russia, including Channel One. The TV commercial, centered around the concept “smooth digestive rhythm like music,” metaphorically expresses the harmony of well-functioning digestive organs through the harmony of music, receiving highly positive feedback from local audiences.
By earning continued recognition for its product excellence from both doctors and patients in Russia and maintaining active promotional efforts, the company aims to strengthen brand recognition and consumer engagement. For 2018, Daehan New Pharm has set a goal of achieving Top 3 Best Drug recognition for the third consecutive year and exceeding a 40% year-on-year sales growth target. |


Home